Abstract
Purpose of the study. To study the clinical efficacy and safety of iron(III)-hydroxide polymaltose (Maltofer) in the treatment of iron deficiency anemia in children. Material and methods . A retrospective study of medical records of pediatic patients with iron deficiency anemia who received iron(III)-hydroxide polymaltose in standard doses during the course of inpatient treatment. Results. Administraton of iron(III)-hydroxide polymaltose was associated with a positive dynamics of the studied hematological parameters. No adverse reactions were reported. Girls demonstrated a more significant increase in hemoglobin levels and a more significant increase in the color index and mean cell hemoglobin compared to boys.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
